ARCHIVES

Broder Appointment Official; Will Keep Retroviral Laboratory, Will Not Serve as NCI Clinical Director

This article is from The Cancer Letter archive.

Vol. 15 No. 01 | January 6, 1989

Download PDF Visit The Full Archive

Related Articles

An Unlucky Streak? Doctors Analyze Errors As Another Cancer Center Offers Apology

June 30, 1995

US Oncology Begins Trial Of Taxotere And Xeloda

September 27, 2002

IOM Panel: NCI Clinical Trials Groups At “Breaking Point,” More Funds Needed.

April 16, 2010

In Brief: Surgical Oncology Program Announcements Due For Publication By June; AACR/ASCO Program

April 17, 1981

Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer

November 28, 2014

FDA Breakthrough Designation Granted to Pfizer’s Palbociclib

April 26, 2013